The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
This reduced piecewise exponential survival software implements the likelihood ratio test and backward elimination procedure in Han, Schell, and Kim (2012 <doi:10.1080/19466315.2012.698945>, 2014 <doi:10.1002/sim.5915>), and Han et al. (2016 <doi:10.1111/biom.12590>). Inputs to the program can be either times when events/censoring occur or the vectors of total time on test and the number of events. Outputs of the programs are times and the corresponding p-values in the backward elimination. Details about the model and implementation are given in Han et al. 2014. This program can run in R version 3.2.2 and above.
Version: | 0.0.2 |
Depends: | R (≥ 3.2.2) |
Imports: | stats, graphics |
Suggests: | knitr, rmarkdown |
Published: | 2020-05-21 |
DOI: | 10.32614/CRAN.package.RPEXE.RPEXT |
Author: | Gang Han [aut, cre], Yu Zhang [aut] |
Maintainer: | Gang Han <hangang.true at gmail.com> |
BugReports: | https://github.com/hangangtrue/RPEXE.RPEXT/issues |
License: | GPL-3 |
URL: | https://github.com/hangangtrue/RPEXE.RPEXT |
NeedsCompilation: | no |
Materials: | README NEWS |
CRAN checks: | RPEXE.RPEXT results |
Reference manual: | RPEXE.RPEXT.pdf |
Vignettes: |
RPEXE.RPEXT |
Package source: | RPEXE.RPEXT_0.0.2.tar.gz |
Windows binaries: | r-devel: RPEXE.RPEXT_0.0.2.zip, r-release: RPEXE.RPEXT_0.0.2.zip, r-oldrel: RPEXE.RPEXT_0.0.2.zip |
macOS binaries: | r-release (arm64): RPEXE.RPEXT_0.0.2.tgz, r-oldrel (arm64): RPEXE.RPEXT_0.0.2.tgz, r-release (x86_64): RPEXE.RPEXT_0.0.2.tgz, r-oldrel (x86_64): RPEXE.RPEXT_0.0.2.tgz |
Old sources: | RPEXE.RPEXT archive |
Please use the canonical form https://CRAN.R-project.org/package=RPEXE.RPEXT to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.